Both in Biotechnology
Scholar Rock Holding vs Relay Therapeutics
Over the past year SRRK returned +48.2% and RLAY returned +157.0%; their daily moves had a correlation of 0.25.
SRRK +48.2% RLAY +157.0%Growth of $1, one year, split-adjusted
| Metric | SRRK | RLAY |
|---|---|---|
| Price | $43.90 | $18.35 |
| Market cap | $5.35B | $4.02B |
| Today | −0.63% | −5.75% |
| 1 month | −4.9% | −0.8% |
| 6 months | −5.3% | +44.3% |
| Year to date | −0.3% | +116.9% |
| 1 year | +50.0% | +151.0% |
| Revenue growth (YoY) | — | −48.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −23916.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 388.5× |
| Net cash | $295.9M | $910.9M |
| Dividend yield | — | — |
| Volatility (60d) | 43.2% | 47.2% |
| Short % of float | 20.3% | 27.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).